NEW YORK (GenomeWeb News) – New England Biolabs will distribute Rubicon Genomics' amplification technology as part of a kit being sold for single-cell amplification, the firms announced today.
Ipswich, Mass.-based New England Biolabs will offer the Single Cell Whole Genome Amplification Kit, which will include the Rubicon technology that enables the amplification of DNA from single cells or extremely low amounts of input DNA. New England Biolabs said that the kit is its first product aimed at the single-cell amplification market.
"This single cell amplification technology has already been widely adopted in the in vitro fertilization (IVF) market, and we are excited at the prospects this product has in research applications," Jim Koziarz, president and CEO of Rubicon, said in a statement.
Terms of the agreement were not disclosed.